menu search

Inozyme Pharma to Present at the Jefferies Healthcare Conference

Inozyme Pharma to Present at the Jefferies Healthcare Conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Douglas A. Treco, Ph.D., the company’s chief executive officer and chairman of the board, will present at the Jefferies Healthcare Conference on Friday, […] The post Inozyme Pharma to Present at the Jefferies Healthcare Conference appeared first... Read More
Posted: Jun 2 2023, 11:30
Author Name: forextv
Views: 110657

Search within

Pages Search Results: